D
Daniel R. Boue
Researcher at Nationwide Children's Hospital
Publications - 66
Citations - 1294
Daniel R. Boue is an academic researcher from Nationwide Children's Hospital. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 17, co-authored 49 publications receiving 983 citations. Previous affiliations of Daniel R. Boue include Boston Children's Hospital & Ohio State University.
Papers
More filters
Journal ArticleDOI
Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors
Amanda M. Haidet,Liza Rizo,Chalonda R. Handy,Priya Umapathi,Amy Eagle,Chris Shilling,Daniel R. Boue,Paul T. Martin,Zarife Sahenk,Jerry R. Mendell,Brian K. Kaspar +10 more
TL;DR: A one-time gene administration of myostatin-inhibitor-proteins is described to enhance muscle mass and strength in normal and dystrophic mouse models for >2 years, even when delivered in aged animals.
Journal ArticleDOI
Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas
Ana Guerreiro Stucklin,Scott Ryall,Kohei Fukuoka,Michal Zapotocky,Michal Zapotocky,Alvaro Lassaletta,Christopher Li,Taylor Bridge,Byungjin Kim,Anthony Arnoldo,Paul E. Kowalski,Yvonne Zhong,Monique Johnson,Claire Li,Arun K. Ramani,Robert Siddaway,Liana Nobre,Pasqualino De Antonellis,Christopher Dunham,Sylvia Cheng,Daniel R. Boue,Daniel R. Boue,Jonathan L. Finlay,Scott L. Coven,Inmaculada de Prada,Marta Perez-Somarriba,Claudia C. Faria,Michael A. Grotzer,Elisabeth J. Rushing,David Sumerauer,Josef Zamecnik,Lenka Krskova,Miguel Garcia Ariza,Ofelia Cruz,Andres Morales La Madrid,Palma Solano,Keita Terashima,Yoshiko Nakano,Koichi Ichimura,Motoo Nagane,Hiroaki Sakamoto,Maria Joao Gil-da-Costa,Roberto Silva,Donna L. Johnston,Jean Michaud,Bev Wilson,Frank van Landeghem,Angelica Oviedo,Angelica Oviedo,P. Daniel McNeely,Bruce Crooks,Iris Fried,Nataliya Zhukova,Jordan R. Hansford,Jordan R. Hansford,Amulya NageswaraRao,Livia Garzia,Mary Shago,Michael Brudno,Meredith S. Irwin,Ute Bartels,Vijay Ramaswamy,Eric Bouffet,Michael D. Taylor,Uri Tabori,Cynthia Hawkins +65 more
TL;DR: It is concluded that infant gliomas comprise 3 subgroups, justifying the need for specialized therapeutic strategies and revealing genetic alterations which may offer therapeutic opportunities.
Journal ArticleDOI
The Congenital Muscular Dystrophies: Recent Advances and Molecular Insights
TL;DR: In muscle diseases with overlapping pathological features, such as CMD, careful attention to the clinical clues can help guide the battery of immunostains necessary to target an unequivocal diagnosis.
Journal ArticleDOI
Survivin, Survivin-2B, and Survivin-deItaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcome.
Jason Fangusaro,Yuying Jiang,Michael P Holloway,Hugo Caldas,V Singh,Daniel R. Boue,John R. Hayes,Rachel A. Altura +7 more
TL;DR: A role for Survivin as a marker of tumour morphology and clinical outcome in medulloblastoma is demonstrated and Survivin may be a promising future prognostic tool and potential biologic target in this malignancy.
Journal ArticleDOI
Outcomes of BRAF V600E pediatric gliomas treated with targeted BRAF inhibition
Liana Nobre,Michal Zapotocky,Michal Zapotocky,Vijay Ramaswamy,Scott Ryall,Julie Bennett,Daniel Alderete,Julia Balaguer Guill,Lorena V Baroni,Ute Bartels,Abhishek Bavle,Miriam Bornhorst,Daniel R. Boue,Adela Cañete,Murali Chintagumpala,Scott L. Coven,Ofelia Cruz,Sonika Dahiya,Peter B. Dirks,Ira J. Dunkel,David D. Eisenstat,Cecile Faure Conter,Elizabeth Finch,Jonathan L. Finlay,Didier Frappaz,Maria Luisa Garrè,Karen Gauvain,Anne Grete Bechensteen,Jordan R. Hansford,Inga Harting,Peter Hauser,Lili-Naz Hazrati,Annie Huang,Sarah Injac,Valentina Iurilli,Matthias A. Karajannis,Gurcharanjeet Kaur,Martin Kyncl,Lenka Krskova,Normand Laperriere,Valerie Larouche,Alvaro Lassaletta,Sarah Leary,Frank Lin,Samantha Mascelli,Tara McKeown,Till Milde,Andres Morales La Madrid,Giovanni Morana,Helena Mörse,Naureen Mushtaq,Diana S Osorio,Roger J. Packer,Zdenek Pavelka,Eduardo Quiroga-Cantero,James T. Rutka,Magnus Sabel,Duarte Salgado,Palma Solano,Jaroslav Sterba,Jack Su,David Sumerauer,Michael D. Taylor,Michael D. Taylor,Helen Toledano,Derek S. Tsang,Mariana Fernandes,Frank van Landeghem,Cornelis M. van Tilburg,Bev Wilson,Olaf Witt,Josef Zamecnik,Eric Bouffet,Cynthia Hawkins,Uri Tabori +74 more
TL;DR: Use of BRAF inhibition results in robust and durable responses in BRAF V600E-mutated PLGG, and prospective studies are required to determine long-term survival and functional outcomes with BRAF inhibitor therapy in childhood gliomas.